Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
Other facts about the use experience come by deduction of the scientific literature on DSIP and other peptides, as well as our extensive interactions with peptide-prescribing physicians: Preparation: If used as an injectable, DSIP ought to come as a dry powder that needs to be reconstituted into a solution
"Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data"
Can I use bac water after the 28-day expiration mark
BPC-157 exists in a regulatory grey area across most jurisdictions, including the UAE
